Similar Management Seen for Dialysis-Requiring AKI, ESKD Patients
THURSDAY, Oct. 5, 2023 (HealthDay News) — Patients with dialysis-requiring acute kidney injury (AKI-D) are prescribed the same dialysis as end-stage kidney disease (ESKD) patients, but some AKI-D patients have the potential to recover, according to a…
Learn MoreStudy Confirms Risk of Gastro Issues for People Taking Wegovy, Ozempic
THURSDAY, Oct. 5, 2023 (HealthDay News) — While many have raved about the powers of popular weight-loss drugs like Wegovy and Ozempic, new research confirms the medications can trigger some nasty gastrointestinal side effects.Known as GLP-1 agonists,…
Learn MoreStudy Confirms Risk of Gastro Issues for People Taking Wegovy, Ozempic
THURSDAY, Oct. 5, 2023 (HealthDay News) — While many have raved about the powers of popular weight-loss drugs like Wegovy and Ozempic, new research confirms the medications can trigger some nasty gastrointestinal side effects.Known as GLP-1 agonists,…
Learn MoreIVIg Reduces Infection Rate in Multiple Myeloma Patients Receiving Anti-BCMA Therapy
THURSDAY, Oct. 5, 2023 (HealthDay News) — Many patients with multiple myeloma treated with anti-B cell maturation antigen (BCMA) therapy have infections, and the rate of infections is significantly lower when patients are receiving intravenous immuno…
Learn MoreIVIg Reduces Infection Rate in Multiple Myeloma Patients Receiving Anti-BCMA Therapy
THURSDAY, Oct. 5, 2023 (HealthDay News) — Many patients with multiple myeloma treated with anti-B cell maturation antigen (BCMA) therapy have infections, and the rate of infections is significantly lower when patients are receiving intravenous immuno…
Learn MoreTirzepatide Bests Semaglutide for Patients With Type 2 Diabetes
THURSDAY, Oct. 5, 2023 (HealthDay News) — Tirzepatide is superior to semaglutide for both blood sugar control and weight loss among people with type 2 diabetes, according to research presented at the European Association for the Study of Diabetes Ann…
Learn MoreTirzepatide Bests Semaglutide for Patients With Type 2 Diabetes
THURSDAY, Oct. 5, 2023 (HealthDay News) — Tirzepatide is superior to semaglutide for both blood sugar control and weight loss among people with type 2 diabetes, according to research presented at the European Association for the Study of Diabetes Ann…
Learn MoreCancer Drug Shortages Persist Across U.S.
THURSDAY, Oct. 5, 2023 (HealthDay News) — U.S. cancer centers continue to have shortages of commonly used chemotherapy drugs, a new survey shows, though the medications are not as scarce as they were last June.The National Comprehensive Cancer Networ…
Learn MoreKetamine Nasal Spray Shows Promise Against Tough-to-Treat Depression
THURSDAY, Oct. 5, 2023 (HealthDay News) — A nasal spray containing a ketamine derivative appears to beat one of the standard drugs used for people with difficult-to-treat depression, a new clinical trial has found.The trial, of nearly 700 people with…
Learn MoreIn Early Trial, Promising Results for Moderna’s Combo COVID-Flu Vaccine
THURSDAY, Oct. 5, 2023 (HealthDay News) — Moderna Inc. announced Wednesday that it has seen positive early results with a new vaccine that would guard against four strains of flu plus COVID-19.In interim findings from a Phase 1/2 trial, the vaccine s…
Learn More